Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

Acorda Therapeutics, Inc. (the "Company") is reporting that its board of directors (the "Board") has accepted Barry Greene's resignation from the Board. As previously disclosed, at the Company's 2021 Annual Meeting of Stockholders held on June 2, 2021 (the "Annual Meeting"), the votes withheld from Barry Greene's re-election to the Company's Board exceeded the votes cast in favor of his re-election. The Company believes the vote was attributable to investor perception that Mr. Greene was over-boarded given the number of other public company boards on which he serves as a director in light of his service as the Chief Executive Officer of another public company. Accordingly, pursuant to the majority vote provisions of the Company's Bylaws, Mr. Greene had tendered his conditional resignation for the Board's consideration.

Under the procedures set forth in the Company's Bylaws, the Nominations and Governance Committee of the Board (the "Committee") considered Mr. Greene's resignation in light of the number of other public company boards on which he serves as a director and prior discussions with Mr. Greene about his desire to reduce his board commitments given his responsibilities as a full time Chief Executive Officer. After considering the resignation and these factors, the Committee recommended to the Board that it accept Mr. Greene's resignation, and on August 20, 2021, the Board accepted Mr. Greene's resignation effective immediately. Mr. Greene did not participate in the deliberations of the Nominations and Governance Committee or the Board with respect to their consideration of his resignation.

The Company is also reporting that on August 22, 2021, Catherine D. Strader, Ph.D., notified the Company of her decision to resign as a member of the Board, effective immediately. Dr. Strader indicated that she made the decision to resign from the Board because she does not believe she can continue devoting the time and attention that membership on the Board would require, owing to other professional and personal interests that she is pursuing. Dr. Strader also indicated that her decision was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

The Company wishes to express its appreciation to Mr. Greene and Dr. Strader for their dedicated service and significant contributions to the Company since joining the Board in 2007 and 2017, respectively.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses